Clinical Trial Update: A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2 trial evaluating safety, tolerability, and efficacy of AZD4547 in urothelial carcinoma is in early stages with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• AZD4547

Snippet

Sponsor: Abbisko Therapeutics Co, Ltd | Conditions: Urothelial Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN